Will using AI in biology be revolutionary? If you’re a scientist, how often do you use Chat GPT or similar AI for your biomedical research? For writing?
Are you more annoyed or enthralled with how AI might impact biology and the daily work of biologists?
In the middle?
Whatever your answers, Anthropic is hoping that in the future you will turn to its new AI tool Claude Science for many of your tasks as a life scientist. Even things like paper writing. Soon, some at Anthropic apparently think that we human scientists will be unneeded (see screenshot below).
AI in biology
Of course, many scientists have already been using AI to help them write papers and grants. In some cases, AI is doing all or almost all the writing.
For these kinds of reasons, reliance on AI in biomedical science writing has sparked debate. NIH requires grants be written by humans and not AI, but how is that enforceable? There are even tools now to make AI-written material seem more human. It’s like the same kind of AI arms race that is happening in classrooms related to cheating.
Here’s some news on the new Claude release: Anthropic releases Claude Science, a product aimed at researchers, the pharma industry, STAT. This is an AI product squarely aimed at biomedical science, both industry and academia.
More reads
- A molecular seesaw drives healthy skin development, Stanford Medicine researchers find, Stanford.
- Genetic diversity of late Neanderthals in northwestern Europe, Nature. Sometimes when I read about neanderthal genetics I think of the whole kerfuffle with George Church writing about the hypothetical idea of cloning neanderthal. Then, unfortunately, these days maybe I think of George Church’s many ties to Jeffrey Epstein. Is anything ever going to come of that? It feels so sad.
- FDA approves Orca Bio’s T cell therapy for blood cancer patients Treatment is an alternative approach to traditional matched-donor stem cell transplants, STAT. This is one of the more exciting news items in 2026 so far.
- Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy, Capricor. This news is somewhat surprising. In the bigger picture, advisory committee meetings are back.
- What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug, CBS News. The store also advertised “Peptides” more generally right up front including BPC-157.